© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
The Viral Hepatitis National Strategic Plan for the United States, released by HHS, offers a road map for the next five years.
Hepatitis A and B can be prevented with vaccines, and hepatitis C can be cured with antiviral treatment.
A coalition of LGBT groups sues the Trump administration over the rule. The lawsuit is “Whitman-Walker Clinic v. HHS.”
But it comes with deep cuts to Medicare, Medicaid, Social Security, cancer funds and other health and science programs.
As sexually transmitted infections spike to all-time highs, these 17 advocacy groups join forces to reverse the trend.
Efforts to control viral hepatitis are falling behind, in part because of the growing opioid epidemic and homelessness crisis.
Older people who learn they have HIV are likely to have been positive for 4.5 years—the longest diagnosis delay of any age group.
The change targets LGBT people and those with chronic conditions. Here’s how patient groups and Lambda Legal respond.
The Trump administration had proposed changing which meds were covered, including HIV and cancer drugs.
Insurance companies can no longer implement harmful co-pay accumulator policies.
A roundup of statements
Health coalition warns the federal government: People with chronic or serious conditions face growing costs at the pharmacy.
He’ll oversee the FDA, Medicare and Medicaid at a time when soaring drug prices remain a contentious political topic.
As lawmakers postpone their vote, advocates and health groups respond to the bill that guts Medicaid. Here’s what they’re saying.
Plans across the state have started placing hep B and C drugs in their highest-cost tiers, a potentially illegal move under the ACA.
The September 18 awareness campaign focuses on older people living with, affected by or at risk of HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.